Congressional Research Service Issues Insight White Paper on Vaccine Adverse Events Reporting System
January 22, 2025
January 22, 2025
WASHINGTON, Jan. 22 (TNSrep) -- The Congressional Research Service issued the following Insight white paper (No. IN12486) on Jan. 16, 2025, by health policy analyst Kavya Sekar:
* * *
The Vaccine Adverse Events Reporting System: Understanding the Data
In general, vaccines undergo rigorous testing for safety through clinical trials before they are licensed (i.e., approved) or authorized for use by the Food and Drug Administration (FDA). These trials, which c . . .
* * *
The Vaccine Adverse Events Reporting System: Understanding the Data
In general, vaccines undergo rigorous testing for safety through clinical trials before they are licensed (i.e., approved) or authorized for use by the Food and Drug Administration (FDA). These trials, which c . . .